Role of protein phosphatase 2A in Drosophila development.

Abstract:

:The molecular cloning of protein phosphatase 2A subunits from Drosophila has provided insights into the role this enzyme plays in developmental processes and in cell cycle regulation. The trimeric holoenzyme containing the catalytic, 65-kDa and 55-kDa regulatory subunits appears to be preferentially expressed in proliferative organs such as the gonads, in the developing nervous system and in early syncytial embryos. Analysis of mutant flies affected in the expression of the 55-kDa regulatory subunit suggests that the holoenzyme containing this subunit plays a pivotal role in cell cycle regulation and cell fate determination. The severity of the mutant phenotype correlates with a decrease in 55-kDa subunit protein levels and reduced protein phosphatase activity towards p34cdc2 phosphorylated proteins. The data support the idea that the 'variable' subunits of protein phosphatase 2A holoenzymes play a critical role in directing substrate specificity.

journal_name

Semin Cancer Biol

authors

Mayer-Jaekel RE,Hemmings BA

doi

10.1006/scbi.1995.0032

subject

Has Abstract

pub_date

1995-08-01 00:00:00

pages

249-56

issue

4

eissn

1044-579X

issn

1096-3650

pii

S1044-579X(85)70032-6

journal_volume

6

pub_type

杂志文章
  • The molecular basis of targeting protein kinases in cancer therapeutics.

    abstract::In this paper, we provide an overview of targeted anticancer therapies with small molecule kinase inhibitors. First, we discuss why a single constitutively active kinase emanating from a variety of aberrant genetic alterations is capable of transforming a normal cell, leading it to acquire the hallmarks of a cancer ce...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2013.04.001

    authors: Tsai CJ,Nussinov R

    更新日期:2013-08-01 00:00:00

  • The JAK/STAT3 axis: A comprehensive drug target for solid malignancies.

    abstract::Intercellular communication between tumor cells, immune cells and the stroma characterises the tumor microenvironment, which is instrumental for establishing the ecological niche that fosters tumor growth and metastasis. While tumor cell intrinsic STAT3 signaling provides a crucial axis to support cell proliferation a...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2017.06.001

    authors: Huynh J,Etemadi N,Hollande F,Ernst M,Buchert M

    更新日期:2017-08-01 00:00:00

  • Enzymes involved in tumor-driven angiogenesis: A valuable target for anticancer therapy.

    abstract::Angiogenesis plays a pivotal role in cancer progression and is required for tissue invasion and metastasis. Starting with Folkman's initial observations in 1971, basic research continued to shed new molecular insight into this multifaceted process, leading to the development of several anti-angiogenic drugs. To date, ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2017.11.005

    authors: Ricciuti B,Foglietta J,Bianconi V,Sahebkar A,Pirro M

    更新日期:2019-06-01 00:00:00

  • Genetic control of the metastatic phenotype.

    abstract::Transfection experiments indicate that a number of genes can induce or suppress the metastatic phenotype. These genes include ten oncogenes, plasminogen activator, and three suppressor genes. The biochemical mechanism(s) whereby each of these genes alters the metastatic phenotype is poorly understood. Hypotheses conce...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:

    authors: Steeg PS

    更新日期:1991-04-01 00:00:00

  • Current and future systemic treatments for renal cell carcinoma.

    abstract::Systemic treatment of renal cell carcinoma has changed dramatically since 2007, with the development and approval of six new agents, which target complex molecular pathways regulating tumour angiogenesis and cell proliferation and survival. These treatments have significantly improved survival times in metastatic rena...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2012.06.004

    authors: Fisher R,Gore M,Larkin J

    更新日期:2013-02-01 00:00:00

  • Extracellular matrix as a solid-state regulator in angiogenesis: identification of new targets for anti-cancer therapy.

    abstract::Angiogenesis, the growth of blood capillaries, is regulated by soluble growth factors and insoluble extracellular matrix (ECM) molecules. Soluble angiogenic mitogens act over large distances to initiate capillary growth whereas changes in ECM govern whether individual cells will grow, differentiate, or involute in res...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:

    authors: Ingber DE

    更新日期:1992-04-01 00:00:00

  • Role of AHR in the control of GBM-associated myeloid cells.

    abstract::Glioblastoma (GBM) is an aggressive and incurable brain tumor; its malignancy has been associated with the activity of tumor infiltrating myeloid cells. Myeloid cells play important roles in the tumor control by the immune response, but also in tumor progression. Indeed, GBM exploits multiple mechanisms to recruit and...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.05.014

    authors: Gabriely G,Quintana FJ

    更新日期:2020-08-01 00:00:00

  • Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications.

    abstract::The global burden of breast cancer (BC) is increasing significantly. This trend is caused by several factors such as late diagnosis, limited treatment options for certain BC subtypes, drug resistance which all lead to poor clinical outcomes. Recent research has reported the role of epigenetic alterations in the mechan...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章

    doi:10.1016/j.semcancer.2020.08.009

    authors: Sher G,Salman NA,Khan AQ,Prabhu KS,Raza A,Kulinski M,Dermime S,Haris M,Junejo K,Uddin S

    更新日期:2020-08-25 00:00:00

  • Out of Warburg effect: An effective cancer treatment targeting the tumor specific metabolism and dysregulated pH.

    abstract::As stated by Otto Warburg nearly a century ago, cancer is a metabolic disease, a fermentation caused by malfunctioning mitochondria, resulting in increased anabolism and decreased catabolism. Treatment should, therefore, aim at restoring the energy yield. To decrease anabolism, glucose uptake should be reduced (ketoge...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2017.01.005

    authors: Schwartz L,Seyfried T,Alfarouk KO,Da Veiga Moreira J,Fais S

    更新日期:2017-04-01 00:00:00

  • PIWI-interacting RNAs in human cancer.

    abstract::P-element-induced wimpy testis (PIWI) interacting RNAs (piRNAs) are a class of small regulatory RNAs mechanistically similar to but much less studied than microRNAs and small interfering RNAs. Today the best understood function of piRNAs is transposon control in animal germ cells, which has earned them the name 'guard...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章

    doi:10.1016/j.semcancer.2020.08.012

    authors: Lin Y,Zheng J,Lin D

    更新日期:2020-09-01 00:00:00

  • The role of exosomes in cancer metastasis.

    abstract::Exosomes are small membrane vesicles with a size ranging from 40 to 100nm. They can serve as functional mediators in cell interaction leading to cancer metastasis. Metastasis is a complex multistep process of cancer cell invasion, survival in blood vessels, attachment to and colonization of the host organ. Exosomes in...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2017.02.006

    authors: Steinbichler TB,Dudás J,Riechelmann H,Skvortsova II

    更新日期:2017-06-01 00:00:00

  • Critical determinants of metastasis.

    abstract::The major cause of death from cancer is due to metastases that are resistant to conventional therapies. Several reasons account for the failure to treat metastases. First, neoplasms are biologically heterogeneous and contain subpopulations of cells with different angiogenic, invasive, and metastatic properties. Second...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.2001.0416

    authors: Fidler IJ

    更新日期:2002-04-01 00:00:00

  • CRISPR/Cas mediated epigenome editing for cancer therapy.

    abstract::The understanding of the relationship between epigenetic alterations, their effects on gene expression and the knowledge that these epigenetic alterations are reversible, have opened up new therapeutic pathways for treating various diseases, including cancer. This has led the research for a better understanding of the...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章

    doi:10.1016/j.semcancer.2020.12.018

    authors: Ansari I,Chaturvedi A,Chitkara D,Singh S

    更新日期:2021-01-06 00:00:00

  • Genetic drivers of NF-κB deregulation in diffuse large B-cell lymphoma.

    abstract::Diffuse large B cell lymphoma (DLBCL) is the most common form of B cell non-Hodgkin lymphoma worldwide and comprises a heterogeneous group of malignancies that originate from the malignant transformation of germinal center (GC) B cells. Over the past decade, significant improvement has been achieved in our understandi...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2016.08.001

    authors: Pasqualucci L,Zhang B

    更新日期:2016-08-01 00:00:00

  • Laminin isoforms in tumor invasion, angiogenesis and metastasis.

    abstract::Laminins are a growing family of alphabetagamma heterotrimeric proteins, commonly found in basement membranes (BMs). These large molecules promote cell adhesion and migration via integrins and other cell-surface receptors. Over 12 laminin isoforms are presently known. The various isoforms have a cell- and tissue-speci...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/S1044-579X(02)00023-8

    authors: Patarroyo M,Tryggvason K,Virtanen I

    更新日期:2002-06-01 00:00:00

  • Autophagy proteins influence endocytosis for MHC restricted antigen presentation.

    abstract::T cells of the adaptive immune system monitor protein degradation products via their presentation on major histocompatibility complex (MHC) molecules to recognize infected cells. Both macroautophagy and endocytosis target intra- and extracellular constituents, respectively, for lysosomal degradation. This results in a...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.03.005

    authors: Münz C

    更新日期:2020-11-01 00:00:00

  • The pan-therapeutic resistance of disseminated tumor cells: Role of phenotypic plasticity and the metastatic microenvironment.

    abstract::Cancer metastasis is the leading cause of mortality in patients with solid tumors. The majority of these deaths are associated with metastatic disease that occurs after a period of clinical remission, anywhere from months to decades following removal of the primary mass. This dormancy is prominent in cancers of the br...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.07.021

    authors: Ma B,Wells A,Clark AM

    更新日期:2020-02-01 00:00:00

  • Emergence and prevention of resistance against small molecule inhibitors.

    abstract::Small molecule inhibitors target specific metabolic pathways in tumor cells and are a promising class of drugs for the treatment of cancers. The best known example is the treatment of chronic myeloid leukemia (CML) with Gleevec. This is a small molecule inhibitor of the Bcr-Abl kinase which has been shown to drive the...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2005.07.002

    authors: Wodarz D,Komarova NL

    更新日期:2005-12-01 00:00:00

  • Mammary tumorigenesis and metastasis in transgenic mice.

    abstract::The transgenic mouse has emerged as an important model system to assess the transforming potential of oncogenes in the mammary epithelium. Mammary gland-specific expression of oncogenes in transgenic mice has resulted in the induction of a variety of phenotypes ranging from benign epithelial hyperplasias to metastatic...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:

    authors: Webster MA,Muller WJ

    更新日期:1994-02-01 00:00:00

  • The microenvironments of multistage carcinogenesis.

    abstract::Overt neoplasia is often the result of a chronic disease process encompassing an extended segment of the lifespan of any species. A common pathway in the natural history of the disease is the appearance of focal proliferative lesions that are known to act as precursors for cancer development. It is becoming increasing...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2008.03.019

    authors: Laconi E,Doratiotto S,Vineis P

    更新日期:2008-10-01 00:00:00

  • The role of Rel/NF-kappa B proteins in viral oncogenesis and the regulation of viral transcription.

    abstract::Rel/NF-kappa B is a ubiquitous transcription factor that consists of multiple polypeptide subunits, and is subject to complex regulatory mechanisms that involve protein-protein interactions, phosphorylation, ubiquitination, proteolytic degradation, and nucleocytoplasmic translocation. The sophisticated control of Rel/...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.1997.0063

    authors: Mosialos G

    更新日期:1997-04-01 00:00:00

  • Carbohydrate antigens on cancer-associated mucin-like molecules.

    abstract::Mucins are large molecular weight glycoproteins characterized by carbohydrate sugars attached via 'O-glycosidic' linkages to serine or threonine. Mucins are synthesized by a variety of epithelial tissues as membrane-bound or secreted proteins, encoded by several distinct mucin genes. Numerous alterations of mucin-asso...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:

    authors: Ho SB,Kim YS

    更新日期:1991-12-01 00:00:00

  • SV40 and the pathogenesis of mesothelioma.

    abstract::Malignant mesothelioma, a tumor of the pleura, pericardium, and peritoneum, is presently a worldwide problem. Current therapy is ineffective in slowing the course of the disease, and median survival from the time of diagnosis is rarely greater than 1 year. While the tumor was almost unknown prior to the second half of...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.2000.0347

    authors: Rizzo P,Bocchetta M,Powers A,Foddis R,Stekala E,Pass HI,Carbone M

    更新日期:2001-02-01 00:00:00

  • The genomic risk of somatic gene therapy.

    abstract::Gene vectors with an untargeted insertion profile have been explored in preclinical models and clinical trials for the transfer of potentially therapeutic genetic information into somatic cells that have a high replicative potential. The gene-modified cell population can be viewed as a genetic mosaic whose complexity ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2010.06.003

    authors: Kustikova O,Brugman M,Baum C

    更新日期:2010-08-01 00:00:00

  • Stress-activated protein kinases-tumor suppressors or tumor initiators?

    abstract::The biology and the pathology of the stress-activated protein kinases (SAPKs; p38s and c-Jun-NH(2)-terminal kinases (JNKs)) are somewhat confusing. In some systems, these enzymes augment cell proliferation whereas in other cells they support growth arrest and tumor suppressing activity. Similarly, in some types of can...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2004.04.006

    authors: Engelberg D

    更新日期:2004-08-01 00:00:00

  • Cell death in unusual but informative and beautiful model organisms.

    abstract::Cancer depends on cell death. It can emerge when cell death is deficient, and it could be treated through cancer-cell-specific induction of cell death. However, our understanding of cell death is still incomplete. While a few classical animal models have helped greatly in this respect, more may be learnt from non-clas...

    journal_title:Seminars in cancer biology

    pub_type: 社论

    doi:10.1016/j.semcancer.2006.11.001

    authors: Golstein P

    更新日期:2007-04-01 00:00:00

  • Progress and promises of epigenetic drugs and epigenetic diets in cancer prevention and therapy: A clinical update.

    abstract::Epigenetic modifications are heritable yet reversible, essential for normal physiological functions and biological development. Aberrant epigenetic modifications, including DNA methylation, histone modification, and non-coding RNA (ncRNA)-mediated gene regulation play a crucial role in cancer progression. In cellular ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章

    doi:10.1016/j.semcancer.2020.12.006

    authors: Mondal P,Natesh J,Penta D,Meeran SM

    更新日期:2020-12-09 00:00:00

  • The emerging roles of F-box proteins in pancreatic tumorigenesis.

    abstract::The role of F-box proteins in pancreatic tumorigenesis is emerging owing to their pivotal and indispensable roles in cell differentiation, cell cycle regulation and proliferation. In this review, we will focus on β-TrCP (β-transducin repeat-containing protein) and two other prototypical mammalian F-box proteins, Fbxw7...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2015.09.004

    authors: Wang H,Maitra A,Wang H

    更新日期:2016-02-01 00:00:00

  • Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy.

    abstract::Cancer-testis antigens (CTAs) are considered as unique and promising cancer biomarkers and targets for cancer therapy. CTAs are multifunctional protein group with specific expression patterns in normal embryonic and adult cells and various types of cancer cells. CTAs are involved in regulating of the basic cellular pr...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2018.08.006

    authors: Gordeeva O

    更新日期:2018-12-01 00:00:00

  • Metabolic reprogramming in cancer cells, consequences on pH and tumour progression: Integrated therapeutic perspectives with dietary lipids as adjuvant to anticancer treatment.

    abstract::While tumours arise from acquired mutations in oncogenes or tumour-suppressor genes, it is clearly established that cancers are metabolic diseases characterized by metabolic alterations in tumour cells, and also non-tumour cells of the host organism resulting in tumour cachexia and patient weakness. In this review, we...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2017.03.004

    authors: Dumas JF,Brisson L,Chevalier S,Mahéo K,Fromont G,Moussata D,Besson P,Roger S

    更新日期:2017-04-01 00:00:00